Holthof, L. C., van der Horst, H. J., Veen, S. E. van H.- van, Ruiter, R. W., Li, F., Buijze, M., Andersen, M. N., Yuan, H., de Bruijn, J., van de Donk, N. W., Lokhorst, H. M., Zweegman, S., Groen, R. W. and Mutis, T. (2020) “Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma”, Haematologica. Pavia, Italy, 105(2), pp. e80-e83. doi: 10.3324/haematol.2018.213314.